Nevertheless, this study steps forward to establishing the comprehensive genetic and immune landscape of the B7 and TNFR families in HCC, and these findings could help provide potential candidates to stratify patients based on response to immune checkpoint therapy. The gene discussed is TNFRSF1A; the disease is hepatocellular carcinoma.